12:02 , Mar 25, 2019 |  BC Extra  |  Financial News

Arch Oncology raises $50M series B to develop anti-CD47 mAb

Backed by new investor Lightchain, Arch Oncology raised $50 million in a series B round to enable the company to advance its anti-CD47 mAb, AO-176, which is in a Phase I trial to treat solid...
16:27 , Dec 15, 2017 |  BC Week In Review  |  Financial News

Allakos raises $100M in series B

Allakos Inc. (San Carlos, Calif.) raised $100 million in a series B round led by New Enterprise Associates. Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital and an undisclosed institutional...
00:47 , Dec 14, 2017 |  BC Extra  |  Financial News

NEA leads $100M Allakos series B

Allakos Inc. (San Carlos, Calif.) raised $100 million in a series B round led by New Enterprise Associates. Redmile Group, Partner Fund Management, Rock Springs Capital, LifeSci Venture Partners, Samsara BioCapital and an undisclosed institutional...
08:00 , Feb 15, 2016 |  BC Week In Review  |  Financial News

Amplyx financial update

Amplyx Pharmaceuticals Inc. , San Diego, Calif.   Business: Infectious   Date announced: 2016-02-09   Note: Amplyx raised $8 million in an extension of a series B round, bringing the total raised in the round...